These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25937836)

  • 1. Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.
    Ezrokhi M; Luo S; Trubitsyna Y; Cincotta AH
    Diabetol Metab Syndr; 2014; 6():104. PubMed ID: 25937836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
    Ezrokhi M; Zhang Y; Luo S; Cincotta AH
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.
    Luo S; Luo J; Cincotta AH
    Chronobiol Int; 2000 Mar; 17(2):155-72. PubMed ID: 10757461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
    Cincotta AH
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.
    Raskin P; Cincotta AH
    Expert Rev Endocrinol Metab; 2016 Mar; 11(2):113-148. PubMed ID: 30058874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).
    Cincotta AH; Meier AH
    Metabolism; 1995 Oct; 44(10):1349-55. PubMed ID: 7476296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
    Tavares G; Marques D; Barra C; Rosendo-Silva D; Costa A; Rodrigues T; Gasparini P; Melo BF; Sacramento JF; Seiça R; Conde SV; Matafome P
    Mol Metab; 2021 Sep; 51():101241. PubMed ID: 33933677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
    Cincotta AH; Cersosimo E; Alatrach M; Ezrokhi M; Agyin C; Adams J; Chilton R; Triplitt C; Chamarthi B; Cominos N; DeFronzo RA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats.
    Luo S; Ezrokhi M; Cominos N; Tsai TH; Stoelzel CR; Trubitsyna Y; Cincotta AH
    Diabetol Metab Syndr; 2021 Jan; 13(1):11. PubMed ID: 33485386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.
    Cincotta AH; Schiller BC; Meier AH
    Metabolism; 1991 Jun; 40(6):639-44. PubMed ID: 1865827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
    Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
    Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian-timed dopamine agonist treatment reverses high-fat diet-induced diabetogenic shift in ventromedial hypothalamic glucose sensing.
    Stoelzel CR; Zhang Y; Cincotta AH
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00139. PubMed ID: 32704560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity.
    Mandour T; Kissebah AH; Wynn V
    Eur J Clin Invest; 1977 Jun; 7(3):181-7. PubMed ID: 19260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome.
    Kraszewski KZ; Cincotta AH
    Int J Mol Med; 2000 Apr; 5(4):349-55. PubMed ID: 10719049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
    Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT
    Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
    Scislowski PW; Tozzo E; Zhang Y; Phaneuf S; Prevelige R; Cincotta AH
    Int J Obes Relat Metab Disord; 1999 Apr; 23(4):425-31. PubMed ID: 10340822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
    Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters.
    Luo S; Liang Y; Cincotta AH
    Neuroendocrinology; 1999 Mar; 69(3):160-6. PubMed ID: 10087448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bromocriptine on responses to stress in spontaneously hypertensive rats.
    Sowers JR
    Hypertension; 1981; 3(5):544-50. PubMed ID: 7028608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.